Stereotaxis Reports 2024 Third Quarter Financial Results
11. November 2024 16:02 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
06. November 2024 08:25 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
23. Oktober 2024 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
21. Oktober 2024 08:41 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis to Present at Upcoming Investor Conferences
09. September 2024 08:40 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
03. September 2024 08:53 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...
Stereotaxis Reports 2024 Second Quarter Financial Results
12. August 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
12. August 2024 16:03 ET
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
22. Juli 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18. Juli 2024 16:13 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...